Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.24.2.u1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance at Dec. 31, 2022   $ 365   $ (46,355)   $ 139,159,811   $ (10,842,569)   $ (117,479,571) $ 10,791,681
Balance, shares at Dec. 31, 2022   36,534   3                
Stock-based compensation:                        
Options       38,834       38,834
Restricted stock units       79,422       79,422
Restricted stock units, shares   39                    
Common stock issued for 401(k) employer matching   $ 3     32,614       32,617
Common stock issued for 401(k) employer matching, shares   242                    
Common stock issued for cash in private placement   $ 59     590,941       591,000
Common stock issued for cash in private placement, shares   5,910                    
Net loss           (2,695,148) (2,695,148)
Other comprehensive loss         (39,799)     (39,799)
Cumulative effect of change upon adoption of ASU 2016-13         $ (111,582)   (111,582)  
Shares issued under the New ELOC, net of offering costs [1]   $ 37     441,372       441,409
Shares issued under the New ELOC, net of offering costs, shares [1]   3,644                    
Relative fair value of warrants issued with 2023 Notes, net of issuance costs [2]       1,506,319       1,506,319
Warrants issued for modification of GGH Notes       134,779       134,779
Reduction of warrant exercise price on new debt issuance       63,502       63,502
Shares issued upon conversion of debt and interest   $ 83     1,571,470       1,571,553
Shares issued upon conversion of debt and interest, shares   8,333                    
Cashless warrant exercise   $ 5     (5)      
Cashless warrant exercise, shares   513                    
True-up adjustment            
True-up adjustment, shares   3                    
Balance at Mar. 31, 2023   $ 552   $ (46,355)   143,619,059   (10,882,368)   (120,286,301) 12,404,587
Balance, shares at Mar. 31, 2023   55,218   3                
Balance at Dec. 31, 2022   $ 365   $ (46,355)   139,159,811   (10,842,569)   (117,479,571) 10,791,681
Balance, shares at Dec. 31, 2022   36,534   3                
Stock-based compensation:                        
Common stock issued for 401(k) employer matching                       $ 32,617
Common stock issued for 401(k) employer matching, shares                       242
Net loss                       $ (7,677,275)
Other comprehensive loss                       (77,792)
Balance at Jun. 30, 2023   $ 681   $ (46,355)   144,599,595   (10,920,361)   (125,268,428) 8,365,132
Balance, shares at Jun. 30, 2023   68,093   3                
Balance at Mar. 31, 2023   $ 552   $ (46,355)   143,619,059   (10,882,368)   (120,286,301) 12,404,587
Balance, shares at Mar. 31, 2023   55,218   3                
Stock-based compensation:                        
Options       38,834       38,834
Restricted stock units       74,978       74,978
Net loss           (4,982,127) (4,982,127)
Other comprehensive loss         (37,993)     (37,993)
Shares issued under the New ELOC, net of offering costs [3]   $ 46     291,551       291,597
Shares issued under the New ELOC, net of offering costs, shares [3]   4,588                    
Shares issued upon conversion of debt and interest   $ 83     575,173       575,256
Shares issued upon conversion of debt and interest, shares   8,288                    
Balance at Jun. 30, 2023   $ 681   $ (46,355)   144,599,595   (10,920,361)   (125,268,428) 8,365,132
Balance, shares at Jun. 30, 2023   68,093   3                
Balance at Dec. 31, 2023   $ 4,808   $ (46,355)   150,631,395   (11,104,706)   (133,789,163) 5,695,979
Balance, shares at Dec. 31, 2023   480,794   3                
Stock-based compensation:                        
Options       17,911       17,911
Restricted stock units   $ 19     74,747       74,766
Restricted stock units, shares   1,841                    
Common stock issued for 401(k) employer matching   $ 35     14,733       14,768
Common stock issued for 401(k) employer matching, shares   3,497                    
Common stock issued for cash in private placement   $ 2,888     1,730,046       1,732,934
Common stock issued for cash in private placement, shares   288,824                    
Net loss           (2,733,646) (2,733,646)
Other comprehensive loss         (36,391)     (36,391)
Balance at Mar. 31, 2024   $ 7,750   $ (46,355)   152,468,832   (11,141,097)   (136,522,809) 4,766,321
Balance, shares at Mar. 31, 2024   774,956   3                
Balance at Dec. 31, 2023   $ 4,808   $ (46,355)   150,631,395   (11,104,706)   (133,789,163) 5,695,979
Balance, shares at Dec. 31, 2023   480,794   3                
Stock-based compensation:                        
Restricted stock units, shares   14,341                    
Common stock issued for 401(k) employer matching                       $ 14,768
Common stock issued for 401(k) employer matching, shares                       3,497
Net loss                       $ (5,363,695)
Other comprehensive loss                       47,810
Balance at Jun. 30, 2024   $ 8,893   $ (46,355)   152,667,334   (11,056,896)   (139,152,858) 2,420,118
Balance, shares at Jun. 30, 2024   889,266   3                
Balance at Mar. 31, 2024   $ 7,750   $ (46,355)   152,468,832   (11,141,097)   (136,522,809) 4,766,321
Balance, shares at Mar. 31, 2024   774,956   3                
Stock-based compensation:                        
Options       17,909       17,909
Restricted stock units   $ 125     81,611       81,736
Restricted stock units, shares   12,500                    
Common stock issued for cash in private placement   $ 166     99,834       100,000
Common stock issued for cash in private placement, shares   16,667                    
Net loss           (2,630,049) (2,630,049)
Other comprehensive loss         84,201     84,201
Anti-dilution shares issued   $ 48     (48)      
Anti-dilution shares issued, shares   4,764                    
Effect of reverse stock split   $ 804     (804)      
Effect of reverse stock split, shares   80,379                    
Balance at Jun. 30, 2024   $ 8,893   $ (46,355)   $ 152,667,334   $ (11,056,896)   $ (139,152,858) $ 2,420,118
Balance, shares at Jun. 30, 2024   889,266   3                
[1] Includes gross proceeds of $480,670, less $39,261 of offering costs
[2] Represents $1,609,935 relative fair value of warrants, less $103,616 of allocable issuance costs
[3] Includes gross proceeds of $316,953, less $25,356 of offering costs